These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21987280)

  • 1. Montelukast and maintenance of steroid-induced remission in eosinophilic esophagitis.
    Filik L
    Dig Dis Sci; 2012 Jan; 57(1):258-9. PubMed ID: 21987280
    [No Abstract]   [Full Text] [Related]  

  • 2. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.
    Lucendo AJ; De Rezende LC; Jiménez-Contreras S; Yagüe-Compadre JL; González-Cervera J; Mota-Huertas T; Guagnozzi D; Angueira T; González-Castillo S; Arias A
    Dig Dis Sci; 2011 Dec; 56(12):3551-8. PubMed ID: 21674173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast Does not Maintain Symptom Remission After Topical Steroid Therapy for Eosinophilic Esophagitis.
    Alexander JA; Ravi K; Enders FT; Geno DM; Kryzer LA; Mara KC; Smyrk TC; Katzka DA
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):214-221.e2. PubMed ID: 27650328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future.
    Stumphy J; Al-Zubeidi D; Guerin L; Mitros F; Rahhal R
    Dis Esophagus; 2011 May; 24(4):229-34. PubMed ID: 21073625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast and fluticasone propionate.
    Nathan R
    Ann Allergy Asthma Immunol; 2003 Dec; 91(6):585; author reply 586-7. PubMed ID: 14700445
    [No Abstract]   [Full Text] [Related]  

  • 6. Eosinophilic oesophagitis: treatment using Montelukast.
    Sinharay R
    Gut; 2003 Aug; 52(8):1228-9. PubMed ID: 12865292
    [No Abstract]   [Full Text] [Related]  

  • 7. Eosinophilic esophagitis.
    Shitrit AB; Reinus C; Zeides S; Braverman D
    Isr Med Assoc J; 2006 Aug; 8(8):587. PubMed ID: 16958256
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.
    Schwartz DA; Pardi DS; Murray JA
    Dig Dis Sci; 2001 Aug; 46(8):1787-90. PubMed ID: 11508684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast as a treatment modality for eosinophilic gastroenteritis.
    De Maeyer N; Kochuyt AM; Van Moerkercke W; Hiele M
    Acta Gastroenterol Belg; 2011 Dec; 74(4):570-5. PubMed ID: 22319970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of eosinophilic gastroenteritis with montelukast.
    Neustrom MR; Friesen C
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):506. PubMed ID: 10452782
    [No Abstract]   [Full Text] [Related]  

  • 11. Montelukast: use in pediatric patients with eosinophilic gastrointestinal disease.
    Vanderhoof JA; Young RJ; Hanner TL; Kettlehut B
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):293-4. PubMed ID: 12548071
    [No Abstract]   [Full Text] [Related]  

  • 12. Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast.
    Quack I; Sellin L; Buchner NJ; Theegarten D; Rump LC; Henning BF
    BMC Gastroenterol; 2005 Jul; 5():24. PubMed ID: 16026609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic oesophagitis: a novel treatment using Montelukast.
    Attwood SE; Lewis CJ; Bronder CS; Morris CD; Armstrong GR; Whittam J
    Gut; 2003 Feb; 52(2):181-5. PubMed ID: 12524397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
    Goh BS; Ismail MI; Husain S
    J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
    Jartti T
    Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biased about the treatment of asthma in children].
    Wickman M; Gustafsson P
    Lakartidningen; 2007 Dec; 104(51-52):3902; author reply 3902-3. PubMed ID: 18232537
    [No Abstract]   [Full Text] [Related]  

  • 17. The leukotriene receptor antagonist montelukast and aortic stenosis.
    Bäck M; Yin L; Nagy E; Ingelsson E
    Br J Clin Pharmacol; 2013 Jan; 75(1):280-1. PubMed ID: 22616719
    [No Abstract]   [Full Text] [Related]  

  • 18. Eosinophilic cystitis: successful long-term treatment with montelukast sodium.
    Sterrett S; Morton J; Perry D; Donovan J
    Urology; 2006 Feb; 67(2):423.e19-423.e21. PubMed ID: 16461108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of leukotriene receptor antagonists in the therapy of bronchial asthma one year following the introduction of Montelukast. Symposium at Munich, 6 March 1999].
    Pneumologie; 1999 Apr; 53(4 Suppl):1-4. PubMed ID: 10368577
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montelukast.
    Hani N; Hartmann K; Casper C; Peters T; Schneider LA; Hunzelmann N; Scharffetter-Kochanek K
    Acta Derm Venereol; 2000 May; 80(3):229. PubMed ID: 10954230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.